Patents
Patents for C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
09/2010
09/21/2010CA2405002C Antitumoral analogs of et-743
08/2010
08/10/2010CA2391832C Oral dosage forms
07/2010
07/28/2010CN101787001A Synthesis process of acesulfame potassium
07/01/2010WO2010072310A1 4-amino-1,2,3- benzoxathiazine derivatives as pesticides
06/2010
06/24/2010US20100159593 Transfection reagents
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/16/2010EP2196461A1 4-Amino-1,2,3-benzoxathiazine-derivatives as pesticides
05/2010
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
04/2010
04/22/2010WO2010044371A1 Insulin secretion stimulator
04/08/2010US20100086955 Small Molecule Inhibitors of Ghrelin O-Acyltransferase
03/2010
03/30/2010CA2418084C Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom
02/2010
02/16/2010US7662957 Method for producing 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound or salt thereof
02/16/2010CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound
01/2010
01/28/2010US20100022500 Macrocyclic Lactams and Pharmaceutical Use Thereof
01/26/2010US7652003 Macrocyclic β-secretase inhibitors
01/07/2010WO2009118712A3 Novel dihydroxypyrrolidine derivatives as anti-cancer agents
12/2009
12/30/2009CN101613310A Method of preparing amine stereoisomers
12/24/2009US20090318686 Method for producing potassium salt of 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound
12/24/2009US20090318685 Method for producing 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound or salt thereof
12/22/2009US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
12/09/2009CN101600730A Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
12/02/2009CN100564367C Triethylamine recovery processing method for production of acesulfame potassium
11/2009
11/05/2009WO2009108720A3 Antagonists of prostaglandin d2 receptors
10/2009
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/15/2009US20090258948 Pharmaceutical salts
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
09/2009
09/30/2009EP1243584B1 Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide
09/03/2009US20090220397 Capture and Release of Acid-Gasses with Acid-Gas Binding Organic Compounds
08/2009
08/20/2009WO2009029317A3 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
08/19/2009EP2089417A2 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
08/13/2009WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
08/11/2009US7572463 Oral dosage forms
08/05/2009CN101501011A Method for producing potassium salt of 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound
08/05/2009CN101501010A Method for producing 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound or salt thereof
07/2009
07/28/2009US7566800 Homogeneous isomerization of cis-2-pentene nitrile to form 3-pentene nitrile
07/28/2009US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity
07/22/2009CN100516054C Sulphonation ring closure process of synthesizing potassium acetylsulfamilate and special device for the same
07/02/2009US20090171080 Intermediate and Process of Preparation of Ecteinascidin Such as Ecteinascidines-583,597 Using Such Intermediate
07/02/2009US20090170910 Wound healing
06/2009
06/30/2009US7553964 Useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands; for example, 5-{4-[3-({2R}-2-methyl-pyrrolidin-1-yl)-cis-cyclobutyl]-phenyl}-pyrimidine
06/18/2009DE112007001830T5 Verfahren zum Herstellen eines Kaliumsalzes von einer 3,4-Dihydro-1,2,3-Oxathiazin-4-ON-2,2-Dioxid-Verbindung A method for producing a potassium salt of a 3,4-dihydro-1,2,3-oxathiazine-4-one-2,2-dioxide compound
06/18/2009DE112007001772T5 Verfahren zum Herstellen einer 3,4-Dihydro-1,2,3-oxathiazin-4on-2,2-dioxid-Verbindung oder eines Salzes davon A method for producing a 3,4-dihydro-1,2,3-oxathiazine-2,2-dioxide 4ON compound or a salt thereof
06/04/2009US20090143583 Transfection reagents
05/2009
05/27/2009EP0934287B1 Heterocyclic esters and amides
05/26/2009US7538129 Diazonamide A analog
05/14/2009US20090124813 Process for Preparing Optically Active Aminopentane Derivative, Intermediate and Process for Preparing Intermediate
05/12/2009US7531668 2-arylcarboxamide-nitrogenous heterocycle compound
05/06/2009CN101426769A Five-membered heterocyclic invertebrate pest control agents
05/06/2009CN101423504A Method for synthesizing chiral sultam containing hetero atom unsymmetrical hydrogenation using Pd as catalyst
05/05/2009US7528137 Compounds, compositions, and methods
04/2009
04/28/2009US7524956 Hemisynthetic method and new compounds
04/14/2009US7517895 Synthetic diazonamides
04/08/2009CN100475822C Synthesis method for producing ecteinascidin compound
04/08/2009CN100475798C Sulfonate derivatives and the use therof as latent acids
03/2009
03/24/2009US7507730 Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators
03/17/2009US7504499 Methods of attaching biological compounds to solid supports using triazine
02/2009
02/12/2009CA2830727A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
02/12/2009CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
02/10/2009US7488468 Water solubility, reduced toxicity; photodynamic therapy; administering near infrared fluorescent contrast agent , exposing to an excitation light, and detecting near infrared fluorescence from the contrast agent
02/10/2009CA2386690C Pharmaceutical tramadol salts
01/2009
01/21/2009EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives
01/20/2009US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
01/20/2009CA2331758C Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
01/13/2009US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
01/07/2009CN101340907A Diazonamide a analog
01/01/2009US20090005363 Organic Compounds
12/2008
12/30/2008US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
12/17/2008EP1716153A4 Methods, compositions, and apparatuses for forming macrocyclic compounds
11/2008
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/20/2008US20080286693 Sulfonate derivatives and the use thereof as latent acids
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
10/2008
10/23/2008US20080262055 Macrocyclic Acyl Guanidines as Beta-Secretase Inhibitors
10/07/2008US7432371 Nanofilm and membrane compositions
10/02/2008DE10351822B4 OLED-Bauelement und Display auf Basis von OLED-Bauelementen mit verbesserter Effizienz OLED device and display on the basis of OLED devices with improved efficiency
09/2008
09/04/2008US20080214870 Method of Preparing Amine Stereoisomers
09/04/2008US20080214526 Macrocyclic Compounds and Compositions Useful as Bace Inhibitors
09/02/2008US7420051 Antitumor agents; microbiocides; antibiotics; forming a 1,4 bridge using a 1-labile, 10-hydroxy, 18-protected hydroxyl, di-6,8-en-5-one fused ring compound. After formation of the 1,4 brige, C-18 protection is removed before spiroamine introduction
08/2008
08/28/2008WO2008102908A1 Haloalkylsulfonanilide derivative
08/26/2008US7417040 hormone sensitive diseases such as prostate hypertrophia, benign prostatic hyperplasia, adenomas and neoplasies of the prostate, prostate cancer, hirsutism, and polycystic ovary syndrome; dibenz[b,f]azocine, dibenzo[b,f][1,4]thiazocine, dibenz[b,f][1,5]oxazocine derivatives; anticancer, antitumor agents
08/19/2008US7414142 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators
08/13/2008CN100410246C Hydrolysis process of synthesizing potassium acetylsulfamilate and special device for the same
08/12/2008US7410969 Antitumoral analogs of ET-743
08/05/2008US7408059 Method for producing 3, 4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound or salt thereof
07/2008
07/30/2008EP1948169A2 Diazonamide a analog
07/30/2008CN100406447C Method for producing 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound or salt thereof
07/24/2008WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use
07/17/2008US20080171737 Cyclic sulfonamide derivatives and methods of their use
07/02/2008CN101213173A Process for production of optically active aminopentane derivative, intermediate and process for producing the intermediate
06/2008
06/19/2008WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use
06/19/2008US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease
06/19/2008US20080146580 Anititumoral Ecteinascidin Derivatives
05/2008
05/28/2008CN100390157C Substituted benzoxazinones and uses thereof
05/14/2008EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
05/13/2008US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O
05/07/2008CN101172983A Substituted phenylacetic acids
05/06/2008US7368576 Treating breast cancer by dministering a fibroblast activation protein alpha inhibitor is a thiazolidine or a pyrrolidine linked to an amino acid by a peptide bond, e.g., L-threo-isoleucyl pyrrolidine, L-allo-isoleucyl thiazolidine, L-allo-isoleucyl pyrrolydine, L-glutaminyl thiazolidine
04/2008
04/09/2008CN101157666A Triethylamine recovery processing method and device for production of acesulfame potassium
1 2 3 4 5 6 7 8 9 10 11